Tumorigenesis Suppressor Pdcd4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression To Suppress Colon Carcinoma Cell Invasion

REFERENCES

• Afonja, O., D. Juste, S. Das, S. Matsuhashi, and H. H. Samuels. 2004. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 23:8135–8145.
   PubMed Web of Science ®Google Scholar
• Anonymous. 2005. KEGG: Kyoto encyclopedia of genes and genomes. 36.0 ed. Kanehisa Laboratories. [Online.] http://www.genome.jp/dbget-bin/show_pathway?hsa04010+11184 .
   Google Scholar
• Azzoni, L., O. Zatsepina, B. Abede, I. M. Bennett, P. Kanakaraj, and B. Perussia. 1998. Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells. J. Immunol. 161:3493–3500.
   PubMed Web of Science ®Google Scholar
• Benbow, U., and C. E. Brinckerhoff. 1997. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15:519–526.
   PubMed Web of Science ®Google Scholar
• Bitomsky, N., M. Bohm, and K. H. Klempnauer. 2004. Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 23:7484–7493.
   PubMed Web of Science ®Google Scholar
• Boomer, J. S., and T. H. Tan. 2005. Functional interactions of HPK1 with adaptor proteins. J. Cell Biochem. 95:34–44.
   PubMedGoogle Scholar
• Bramhall, S. R., J. P. Neoptolemos, G. W. Stamp, and N. R. Lemoine. 1997. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J. Pathol. 182:347–355.
   PubMed Web of Science ®Google Scholar
• Brown, E. J., and S. L. Schreiber. 1996. A signaling pathway to translational control. Cell 86:517–520.
   PubMed Web of Science ®Google Scholar
• Chauhan, D., D. Auclair, E. K. Robinson, T. Hideshima, G. Li, K. Podar, D. Gupta, P. Richardson, R. L. Schlossman, N. Krett, L. B. Chen, N. C. Munshi, and K. C. Anderson. 2002. Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays. Oncogene 21:1346–1358.
   PubMed Web of Science ®Google Scholar
• Chen, Y. H., T. Knosel, G. Kristiansen, A. Pietas, M. E. Garber, S. Matsuhashi, I. Ozaki, and I. Petersen. 2003. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J. Pathol. 200:640–646.
   PubMed Web of Science ®Google Scholar
• Cmarik, J. L., H. Min, G. Hegamyer, S. Zhan, M. Kulesz-Martin, H. Yoshinaga, S. Matsuhashi, and N. H. Colburn. 1999. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc. Natl. Acad. Sci. USA. 96:14037–14042.
   PubMed Web of Science ®Google Scholar
• Cooper, S. J., J. MacGowan, J. Ranger-Moore, M. R. Young, N. H. Colburn, and G. T. Bowden. 2003. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model. Mol. Cancer Res. 1:848–854.
   PubMed Web of Science ®Google Scholar
• Crawford, H. C., and L. M. Matrisian. 1996. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49:20–37.
   PubMedGoogle Scholar
• Curran, S., and G. I. Murray. 2000. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur. J. Cancer 36:1621–1630.
   PubMed Web of Science ®Google Scholar
• De Benedetti, A., and A. L. Harris. 1999. eIF4E expression in tumors: its possible role in progression of malignancies. Int. J. Biochem. Cell Biol. 31:59–72.
   PubMed Web of Science ®Google Scholar
• Dhar, A., J. Hu, R. Reeves, L. M. Resar, and N. H. Colburn. 2004. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation. Oncogene 23:4466–4476.
   PubMed Web of Science ®Google Scholar
• Dong, Z., H. C. Crawford, V. Lavrovsky, D. Taub, R. Watts, L. M. Matrisian, and N. H. Colburn. 1997. A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes. Mol. Carcinog. 19:204–212.
   PubMed Web of Science ®Google Scholar
• Goke, A., R. Goke, A. Knolle, H. Trusheim, H. Schmidt, A. Wilmen, R. Carmody, B. Goke, and Y. H. Chen. 2002. DUG is a novel homologue of translation initiation factor 4G that binds eIF4A. Biochem. Biophys. Res. Commun. 297:78–82.
   PubMed Web of Science ®Google Scholar
• Goke, R., C. Gregel, A. Goke, R. Arnold, H. Schmidt, and B. Lankat-Buttgereit. 2004. Programmed cell death protein 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tumor cells. Ann. N. Y. Acad. Sci. 1014:220–221.
   PubMedGoogle Scholar
• Hennigan, R. F., K. L. Hawker, and B. W. Ozanne. 1994. Fos-transformation activates genes associated with invasion. Oncogene 9:3591–3600.
   PubMedGoogle Scholar
• Hu, M. C., W. R. Qiu, X. Wang, C. F. Meyer, and T. H. Tan. 1996. Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK/SAPK kinase cascade. Genes Dev. 10:2251–2264.
   PubMed Web of Science ®Google Scholar
• Jansen, A. P., C. E. Camalier, and H. N. Colburn. 2005. Epidermal expression of the translation inhibitor Pdcd4 suppresses tumorigenesis. Cancer Res. 65:6034–6041.
   PubMedGoogle Scholar
• Jansen, A. P., C. E. Camalier, C. Stark, and N. H. Colburn. 2004. Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol. Cancer Ther. 3:103–110.
   PubMedGoogle Scholar
• Kang, M. J., H. S. Ahn, J. Y. Lee, S. Matsuhashi, and W. Y. Park. 2002. Up-regulation of PDCD4 in senescent human diploid fibroblasts. Biochem. Biophys. Res. Commun. 293:617–621.
   PubMedGoogle Scholar
• Kiefer, F., L. A. Tibbles, M. Anafi, A. Janssen, B. W. Zanke, N. Lassam, T. Pawson, J. R. Woodgett, and N. N. Iscove. 1996. HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway. EMBO J. 15:7013–7025.
   PubMed Web of Science ®Google Scholar
• Lamb, R. F., R. F. Hennigan, K. Turnbull, K. D. Katsanakis, E. D. MacKenzie, G. D. Birnie, and B. W. Ozanne. 1997. AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol. Cell. Biol. 17:963–976.
   PubMed Web of Science ®Google Scholar
• Lankat-Buttgereit, B., C. Gregel, A. Knolle, A. Hasilik, R. Arnold, and R. Goke. 2004. Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II. Mol. Cell. Endocrinol. 214:149–153.
   PubMed Web of Science ®Google Scholar
• Ling, P., C. F. Meyer, L. P. Redmond, J. W. Shui, B. Davis, R. R. Rich, M. C. Hu, R. L. Wange, and T. H. Tan. 2001. Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling. J. Biol. Chem. 276:18908–18914.
   PubMed Web of Science ®Google Scholar
• Ling, P., Z. Yao, C. F. Meyer, X. S. Wang, W. Oehrl, S. M. Feller, and T. H. Tan. 1999. Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase. Mol. Cell. Biol. 19:1359–1368.
   PubMedGoogle Scholar
• Liou, J., F. Kiefer, A. Dang, A. Hashimoto, M. H. Cobb, T. Kurosaki, and A. Weiss. 2000. HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1. Immunity 12:399–408.
   PubMedGoogle Scholar
• Ma, W., C. Xia, P. Ling, M. Qiu, Y. Luo, T. H. Tan, and M. Liu. 2001. Leukocyte-specific adaptor protein Grap2 interacts with hematopoietic progenitor kinase 1 (HPK1) to activate JNK signaling pathway in T lymphocytes. Oncogene 20:1703–1714.
   PubMed Web of Science ®Google Scholar
• Marconcini, L., S. Marchio, L. Morbidelli, E. Cartocci, A. Albini, M. Ziche, F. Bussolino, and S. Oliviero. 1999. c-Fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc. Natl. Acad. Sci. USA. 96:9671–9676.
   PubMed Web of Science ®Google Scholar
• Onishi, Y., and H. Kizaki. 1996. Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors. Biochem. Biophys. Res. Commun. 228:7–13.
   PubMedGoogle Scholar
• Ozanne, B. W., L. McGarry, H. J. Spence, I. Johnston, J. Winnie, L. Meagher, and G. Stapleton. 2000. Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme. Eur. J. Cancer 36:1640–1648.
   PubMed Web of Science ®Google Scholar
• Pilcher, B. K., J. A. Dumin, B. D. Sudbeck, S. M. Krane, H. G. Welgus, and W. C. Parks. 1997. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J. Cell Biol. 137:1445–1457.
   PubMed Web of Science ®Google Scholar
• Proud, C. G. 1994. Translation. Turned on by insulin. Nature 371:747–748.
   PubMedGoogle Scholar
• Reeves, R., D. D. Edberg, and Y. Li. 2001. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell. Biol. 21:575–594.
   PubMed Web of Science ®Google Scholar
• Robinson, M. J., S. A. Stippec, E. Goldsmith, M. A. White, and M. H. Cobb. 1998. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr. Biol. 8:1141–1150.
   PubMed Web of Science ®Google Scholar
• Sauer, K., J. Liou, S. B. Singh, D. Yablonski, A. Weiss, and R. M. Perlmutter. 2001. Hematopoietic progenitor kinase 1 associates physically and functionally with the adaptor proteins B cell linker protein and SLP-76 in lymphocytes. J. Biol. Chem. 276:45207–45216.
   PubMedGoogle Scholar
• Shibahara, K., M. Asano, Y. Ishida, T. Aoki, T. Koike, and T. Honjo. 1995. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 166:297–301.
   PubMed Web of Science ®Google Scholar
• Shin, E. Y., S. Y. Kim, and E. G. Kim. 2001. c-Jun N-terminal kinase is involved in motility of endothelial cell. Exp. Mol. Med. 33:276–283.
   PubMedGoogle Scholar
• Shin, M., C. Yan, and D. Boyd. 2002. An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression. Biochim. Biophys. Acta 1589:311–316.
   PubMed Web of Science ®Google Scholar
• Taguchi, A., D. C. Blood, G. del Toro, A. Canet, D. C. Lee, W. Qu, N. Tanji, Y. Lu, E. Lalla, C. Fu, M. A. Hofmann, T. Kislinger, M. Ingram, A. Lu, H. Tanaka, O. Hori, S. Ogawa, D. M. Stern, and A. M. Schmidt. 2000. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405:354–360.
   PubMed Web of Science ®Google Scholar
• Vasilevskaya, I., and P. J. O'Dwyer. 2003. Role of Jun and Jun kinase in resistance of cancer cells to therapy. Drug Resist. Update 6:147–156.
   PubMed Web of Science ®Google Scholar
• Yang, H. S., M. H. Cho, H. Zakowicz, G. Hegamyer, N. Sonenberg, and N. H. Colburn. 2004. A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol. Cell. Biol. 24:3894–3906.
   PubMed Web of Science ®Google Scholar
• Yang, H. S., A. P. Jansen, A. A. Komar, X. Zheng, W. C. Merrick, S. Costes, S. J. Lockett, N. Sonenberg, and N. H. Colburn. 2003. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol. Cell. Biol. 23:26–37.
   PubMed Web of Science ®Google Scholar
• Yang, H. S., A. P. Jansen, R. Nair, K. Shibahara, A. K. Verma, J. L. Cmarik, and N. H. Colburn. 2001. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation. Oncogene 20:669–676.
   PubMed Web of Science ®Google Scholar
• Yang, H. S., J. L. Knies, C. Stark, and N. H. Colburn. 2003. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 22:3712–3720.
   PubMedGoogle Scholar
• Yuspa, S. H. 1998. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. J. Dermatol. Sci. 17:1–7.
   PubMedGoogle Scholar
• Zakowicz, H., H. S. Yang, C. Stark, A. Wlodawer, N. Laronde-Leblanc, and N. H. Colburn. 2005. Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI. RNA 11:261–274.
   PubMedGoogle Scholar
• Zhang, Z., and R. N. DuBois. 2001. Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene 20:4450–4456.
   PubMed Web of Science ®Google Scholar
• Zhou, G., S. C. Lee, Z. Yao, and T. H. Tan. 1999. Hematopoietic progenitor kinase 1 is a component of transforming growth factor beta-induced c-Jun N-terminal kinase signaling cascade. J. Biol. Chem. 274:13133–13138.
   PubMed Web of Science ®Google Scholar